NORCROSS, Ga., April 2 /PRNewswire/ -- Metametrix Clinical Laboratory (http://www.metametrix.com), a leader in nutritional and metabolic testing, today announced the introduction of GI Effects Stool Profiles. This latest innovation uses DNA analysis to increase the accuracy of test results and identify 100% of microbiota present. This revolution in testing should provide better information to healthcare providers treating patients with gastrointestinal symptoms.
GI Effects offers significant improvements over older culture methods for stool analysis testing, including increased accuracy and sensitivity, reduced turnaround time, a single sample collection, and an overall better value. The automated technology provides results in less than half the time of a standard stool culture, while increasing patient compliance due to a single sample collection. GI Effects also combines all traditional components of stool analysis, plus tests pathogens, identifies anaerobes, and more at no additional charge.
The increased accuracy and sensitivity are gained from DNA analysis as well. PCR can detect pathogens in as few as 5 cells per gram - a 5000-fold increase in sensitivity over old stool technology. This combined with the ability to identify anaerobes, the majority of microbiota composed in the human gut, allows unprecedented views of gastrointestinal operation.
Metametrix also offers additional profiles related to gastrointestinal function, including the Organix(TM) Profile and the Allergix(TM) IgG4 Profile. For a complete list of Metametrix laboratory services and related research, visit the website at: http://www.metametrix.com.
For Information: http://www.metametrix.com Contact: inquiries@metametrix.com Phone: 800-221-4640 International Phone: 001-886-557-3805
Metametrix Clinical Laboratory
CONTACT: Jennifer Holmes, Product Marketing Manager of Metametrix ClinicalLaboratory, +1-800-221-4640, inquiries@metametrix.com
Web site: http://www.metametrix.com/